BioNTech shares surge as vaccine-maker's profits soar on booming outlook

German pharmaceutical maker BioNTech, which developed the first widely used coronavirus vaccine with Pfizer, swung to a huge profit in the second quarter on record sales.

source https://www.cbc.ca/news/business/biontech-earnings-1.6134619?cmp=rss